金沙检测线路js95(中国)股份有限公司-Official website

You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Brief News on Innovation
Company News Brief News on Innovation
China’s Independently Developed TEER GeminiOne Gained Further Evidence: Comparative Hemodynamic and Biomechanical Evaluation
2025-07-02 13:44:49

In July 2025, Dr. Jianfeng Chen, leading the R&D team at Peijia Medical, collaborated with Prof. Saibal Kar from Los Robles Regional Medical Center (USA), Prof. Zhaoming He from Texas Tech University, and Dr. Dongyang Xu from Worcester Polytechnic Institute published a comparative analysis of the hemodynamic and biomechanical performance of Peijia Medical’s GeminiOne mitral valve edge-to-edge repair device. The study used in vitro DMR and FMR models to evaluate the immediate MR reduction and leaflet grasping stability of GeminiOne (GEM) versus MitraClip (MC).

裁剪旋转.jpeg

Results showed that GEM0626 and MC XTW provided comparable MR reduction. However, GEM0626 demonstrated superior leaflet stability, requiring greater dislodgement force—suggesting potential for better long-term clinical outcomes.

For more information, please visit: https://mp.weixin.qq.com/s/Dk_W9O7Q5_Zy-JRLmCxy3g


Top
XML 地图